CGMP Deviations; presence of N-nitroso-Furosemide (NNF) above the recommended intake limit.
Classification
Class II
Status
Ongoing
Lot
Lots# H03125, H03225, H03325, Exp Date: 2027/08
Date
Disclaimer: This tool indexes published US FDA drug-enforcement recall records from all countries, limited to the latest five years. A company or product not appearing here is not proof that it is compliant, approved, safe, or free of FDA action.